Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             94 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease Arenal, A.
2003
12 3 p. 84-85
2 p.
artikel
2 Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. A randomized controlled clinical trial Kay, J.
2003
12 3 p. 67-68
2 p.
artikel
3 A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients Nathoe, H.M.
2003
12 3 p. 87-
1 p.
artikel
4 Advances for treating in-hospital cardiac arrest: safety and effectiveness of a new automatic external cardioverter-defibrillator Martinez-Rubio, A.
2003
12 3 p. 80-
1 p.
artikel
5 A man with congestive heart failure and left ventricular assist device placement 2003
12 3 p. 59-
1 p.
artikel
6 Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction Essebag, V.
2003
12 3 p. 84-
1 p.
artikel
7 Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis Rothwell, P.M.
2003
12 3 p. 88-
1 p.
artikel
8 Antibiotic therapy after acute myocardial infarction. A prospective randomized study Zahn, R.
2003
12 3 p. 35-36
2 p.
artikel
9 Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers? Gavras, I.
2003
12 3 p. 14-
1 p.
artikel
10 Asymptomatic or “silent” atrial fibrillation. frequency in untreated patients and patients receiving azimilide Page, R.L.
2003
12 3 p. 83-
1 p.
artikel
11 Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation Pagani, F.P
2003
12 3 p. 52-53
2 p.
artikel
12 Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention Lincoff, A.M.
2003
12 3 p. 65-66
2 p.
artikel
13 Burden of systolic and diastolic ventricular dysfunction in the community appreciating the scope of the heart failure epidemic Redfield, M.M.
2003
12 3 p. 50-51
2 p.
artikel
14 Cardiac benefits of fish consumption may depend on the type of fish meal consumed. The Cardiovascular Health Study Mozaffarian, D.
2003
12 3 p. 29-30
2 p.
artikel
15 Cardiac resynchronization and death from progressive heart failure. a meta-analysis of randomized controlled trials Bradley, D.J.
2003
12 3 p. 81-82
2 p.
artikel
16 Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting Ansari, M.
2003
12 3 p. 48-
1 p.
artikel
17 Cholesterol-lowering drugs and risk of age-related maculopathy: prospective cohort study and cumulative exposure measurement van Leeuwen, R.
2003
12 3 p. 32-
1 p.
artikel
18 Clinical efficacy of Doppler-echocardiographic indices of aortic valve stenosis: a comparative test-based analysis of outcome Bermejo, J.
2003
12 3 p. 47-
1 p.
artikel
19 Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial Nakao, N.
2003
12 3 p. 35-
1 p.
artikel
20 Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease Sdringola, S.
2003
12 3 p. 31-32
2 p.
artikel
21 Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea Logeart, D.
2003
12 3 p. 49-50
2 p.
artikel
22 Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (The Advicor vs. other cholesterol-modulating agents trial evaluation [ADVOCATE]) Bays, H.E.
2003
12 3 p. 33-
1 p.
artikel
23 Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines Bozkurt, B.
2003
12 3 p. 50-
1 p.
artikel
24 Cost implications of the use of ramipril in high-risk patients based on the heart outcomes prevention evaluation (HOPE) study Lamy, A.
2003
12 3 p. 31-
1 p.
artikel
25 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy American women Ridker, P.M.
2003
12 3 p. 33-34
2 p.
artikel
26 Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation Wik, L.
2003
12 3 p. 79-
1 p.
artikel
27 Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment Azeka, E.
2003
12 3 p. 92-93
2 p.
artikel
28 Developmental outcome of patients with hypoplastic left heart syndrome treated with heart transplantation Ikle, L.
2003
12 3 p. 92-
1 p.
artikel
29 Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery Koplan, B.A.
2003
12 3 p. 88-
1 p.
artikel
30 Diagnostic usefulness and impact on management of transesophageal echocardiography in surgical intensive care units Bruch, C.
2003
12 3 p. 46-
1 p.
artikel
31 Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy Seferovic, P.M.
2003
12 3 p. 13-
1 p.
artikel
32 Early and late effects of clopidogrel in patients with acute coronary syndromes Yusuf, S.
2003
12 3 p. 69-
1 p.
artikel
33 Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns Koppel, R.I.
2003
12 3 p. 91-
1 p.
artikel
34 Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy Anderson, T.J.
2003
12 3 p. 15-
1 p.
artikel
35 Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization Medina-Ravell, V.A.
2003
12 3 p. 82-
1 p.
artikel
36 Effect of left ventricular outflow tract in hypertrophic cardiomyopathy Maron, M.S
2003
12 3 p. 52-
1 p.
artikel
37 Effects of initiating carvedilol in patients with severe chronic heart failure. Results from the COPERNICUS study Krum, H.
2003
12 3 p. 48-
1 p.
artikel
38 Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction Harjai, K.J.
2003
12 3 p. 66-67
2 p.
artikel
39 Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT) Latini, R.
2003
12 3 p. 49-
1 p.
artikel
40 Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance Shekelle, P.G.
2003
12 3 p. 29-
1 p.
artikel
41 Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome Shimizu, W.
2003
12 3 p. 80-81
2 p.
artikel
42 Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death Gitt, A.K.
2003
12 3 p. 54-
1 p.
artikel
43 Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome Takenaka, K.
2003
12 3 p. 81-
1 p.
artikel
44 Frequent ventricular ectopy after exercise as a predictor of death Frolkis, J.P.
2003
12 3 p. 82-83
2 p.
artikel
45 Gender, age, and heart failure with preserved left ventricular systolic function Masoudi, F.A.
2003
12 3 p. 51-
1 p.
artikel
46 Gender differences in recovery after coronary artery bypass surgery Vaccarino, V.
2003
12 3 p. 87-88
2 p.
artikel
47 Glycemic effects of postmenopausal hormone therapy: the heart attack and estrogen/progestin replacement study. A randomized, double-blind, placebo-controlled trial Kanaya, A.M.
2003
12 3 p. 34-
1 p.
artikel
48 Haploinsufficiency in combination with aging causes SCN5A-linked hereditary lenegre disease Probst, V.
2003
12 3 p. 81-
1 p.
artikel
49 Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients Haude, M.
2003
12 3 p. 66-
1 p.
artikel
50 How should I combine β-blockers, ACE inhibitors and ARBs in the management of heart failure? Campbell, Duncan John
2003
12 3 p. 55-58
4 p.
artikel
51 Impact of glucose intolerance and insulin resistance on cardiac structure and function. sex-related differences in the Framingham heart study Rutter, M.K.
2003
12 3 p. 34-35
2 p.
artikel
52 Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials Ezekowitz, J.A.
2003
12 3 p. 79-
1 p.
artikel
53 Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events Schinkel, A.F.L.
2003
12 3 p. 45-46
2 p.
artikel
54 Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors Freeman, R.V.
2003
12 3 p. 12-
1 p.
artikel
55 Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest Lemaitre, R.
2003
12 3 p. 79-80
2 p.
artikel
56 Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy. A prognostic study with Fourier phase analysis of radionuclide angioscintigraphy Fauchier, L.
2003
12 3 p. 54-
1 p.
artikel
57 Intracardiac echocardiography guided device closure of atrial septal defects Mullen, M.J.
2003
12 3 p. 45-
1 p.
artikel
58 Intramural hematoma of the aorta: predictors of progression to dissection and rupture Von Kodolitsch, Y.
2003
12 3 p. 15-
1 p.
artikel
59 Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries Bonvini, R.
2003
12 3 p. 69-
1 p.
artikel
60 Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? Yetman, A.T.
2003
12 3 p. 15-
1 p.
artikel
61 Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy Olivotto, I.
2003
12 3 p. 45-
1 p.
artikel
62 Mechanism of syncope in patients with positive adenosine triphosphate tests Donateo, P.
2003
12 3 p. 83-
1 p.
artikel
63 Metabolic syndrome: what is it and how should I treat it? Grundy, Scott M
2003
12 3 p. 37-40
4 p.
artikel
64 Nephrotoxic effects in high-risk patients undergoing angiography Aspelin, P.
2003
12 3 p. 67-
1 p.
artikel
65 Oral health and peripheral arterial disease Hung, H.
2003
12 3 p. 36-
1 p.
artikel
66 Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs. optimized medical treatment strategy. one-year results of the randomized TIME trial Pfisterer, M.
2003
12 3 p. 11-
1 p.
artikel
67 Outcomes of clinically significant idiopathic pericardial effusion requiring intervention Tsang, T.S.M.
2003
12 3 p. 13-14
2 p.
artikel
68 Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction Vasan, R.S.
2003
12 3 p. 30-
1 p.
artikel
69 Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency Tonelli, M.
2003
12 3 p. 32-
1 p.
artikel
70 Prenatal diagnosis by echocardiogram in the outcome of absent pulmonary valve syndrome Razavi, R.S.
2003
12 3 p. 91-
1 p.
artikel
71 Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients Curtis, L.H.
2003
12 3 p. 80-
1 p.
artikel
72 Quality of care and the practicing cardiologist Brush Jr., John E
2003
12 3 p. 16-20
5 p.
artikel
73 Randomized evaluation of the safety and efficacy of enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide Goodman, S.G.
2003
12 3 p. 65-
1 p.
artikel
74 Relative intensity of physical activity and risk of coronary heart disease Lee, I.-Min
2003
12 3 p. 31-
1 p.
artikel
75 Renal artery stenosis: who to screen and how to treat? Mukherjee, Debabrata
2003
12 3 p. 70-75
6 p.
artikel
76 Risk factors and secondary prevention in women with heart disease: the heart and estrogen/progestin replacement study Vittinghoff, E.
2003
12 3 p. 34-
1 p.
artikel
77 RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema. A prospective, multicenter, double-blind, placebo-controlled study Kaluski, E.
2003
12 3 p. 49-
1 p.
artikel
78 Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men Mukamal, K.J.
2003
12 3 p. 30-
1 p.
artikel
79 Selective use of diagnostic tests in patients with syncope of unknown cause Garcia-Cevera, R.
2003
12 3 p. 83-
1 p.
artikel
80 Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation Knot, U.N.
2003
12 3 p. 53-
1 p.
artikel
81 Should volume standards for cardiovascular surgry focus only on high-risk patients? Goodney, P.P.
2003
12 3 p. 87-
1 p.
artikel
82 Simvastatin initiated early after heart transplantation: 8-year prospective experience Wenke, K.
2003
12 3 p. 53-
1 p.
artikel
83 Soluble CD40 ligand in acute coronary syndromes Heeschen, C.
2003
12 3 p. 12-13
2 p.
artikel
84 Survey of current practice of pediatric electrophysiologists for asymptomatic Wolff-Parkinson-White syndrome Campbell, R.M.
2003
12 3 p. 91-92
2 p.
artikel
85 The American Society for HIPAA* compliance presents: HIPAA SAP I, A HIPAA self-assessment program See, Martin R
2003
12 3 p. 22-24
3 p.
artikel
86 The answer is: 2003
12 3 p. 60-
1 p.
artikel
87 The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure. A randomized, controlled trial Tepel, M.
2003
12 3 p. 12-
1 p.
artikel
88 The editor Eagle, Kim A
2003
12 3 p. 21-
1 p.
artikel
89 The underutilization of cardiac medications of proven benefit, 1990 to 2002 Stafford, R.S.
2003
12 3 p. 14-
1 p.
artikel
90 The VIVA trial—vascular endothelial growth factor in ischemia for vascular angiogenesis Henry, T.D.
2003
12 3 p. 68-69
2 p.
artikel
91 Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients Kaul, P.
2003
12 3 p. 11-
1 p.
artikel
92 Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern. results from a large prospective long-term follow-up study Pappone, C.
2003
12 3 p. 84-
1 p.
artikel
93 Validation of a brief observation period for patients with cocaine-associated chest pain Weber, J.E.
2003
12 3 p. 14-
1 p.
artikel
94 Valvular flow abnormalities are often identified by a resting focused Doppler examination performed at the time of stress echocardiography Gaur, A.
2003
12 3 p. 46-47
2 p.
artikel
                             94 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland